Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists

被引：79

作者：

Fernández-Nebro, A

Tomero, E

Ortiz-Santamaría, V

Castro, MC

Olivé, A

de Haro, M

García-Vicuña, R

González-Mari, MV

Laffón, A

García-Vicuña, R

机构：

[1] Univ Malaga, Hosp Virgen Victoria, Rheumatol Sect, E-29071 Malaga, Spain

[2] Hosp Gen Segovia, Rheumatol Sect, Segovia, Spain

[3] Univ Barcelona, Hosp Germans Trias & Pujol, Rheumatol Sect, Barcelona, Spain

[4] Hosp Univ Reina Sofia, Rheumatol Serv, Cordoba, Spain

[5] Univ Autonoma Madrid, Hosp Univ Princesa, Rheumatol Serv, Madrid, Spain

来源：

AMERICAN JOURNAL OF MEDICINE | 2005年 / 118卷 / 05期

关键词：

D O I：

10.1016/j.amjmed.2005.01.028

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：552 / 556

页数：5

共 19 条

[11] Infliximab and methotrexate in the treatment of rheumatoid arthritis [J].

Lipsky, PE ;

van der Heijde, DMFM ;

St Clair, EW ;

Furst, DE ;

Breedveld, FC ;

Kalden, JR ;

Smolen, JS ;

Weisman, M ;

Emery, P ;

Feldmann, M ;

Harriman, GR ;

Maini, RN .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22) :1594-1602

[12] Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate:: a randomised phase III trial [J].

Maini, R ;

St Clair, EW ;

Breedveld, F ;

Furst, D ;

Kalden, J ;

Weisman, M ;

Smolen, J ;

Emery, P ;

Harriman, G ;

Feldmann, M ;

Lipsky, P .

LANCET, 1999, 354 (9194) :1932-1939

[13]

McCarthy ET, 1998, J AM SOC NEPHROL, V9, P433

[14] Amyloidosis in a nationwide series of 1666 subjects with rheumatoid arthritis who died during 1989 in Finland [J].

Myllykangas-Luosujärvi, R ;

Aho, K ;

Kautiainen, H ;

Hakala, M .

RHEUMATOLOGY, 1999, 38 (06) :499-503

[15] Anti-TNF treatment in secondary amyloidosis [J].

Ortiz-Santamaria, V ;

Valls-Roc, M ;

Sanmartí, M ;

Olivé, A .

RHEUMATOLOGY, 2003, 42 (11) :1425-1426

[16] Heart rate variability as a predictor of mortality in patients with AA and AL amyloidosis [J].

Reyners, AKL ;

Hazenberg, BPC ;

Reitsma, WD ;

Smit, AJ .

EUROPEAN HEART JOURNAL, 2002, 23 (02) :157-161

[17] Resolution with etanercept of nephrotic syndrome due to renal AA amyloidosis in adult Still's disease [J].

Serratrice, J ;

Granel, B ;

Disdier, P ;

Weiller, PL .

AMERICAN JOURNAL OF MEDICINE, 2003, 115 (07) :589-590

[18]

TRIGER DR, 1973, Q J MED, V42, P15

[19] Benefit of anti-TNFα treatment for nephrotic syndrome in a patient with juvenile inflammatory bowel disease associated spondyloarthropathy complicated with amyloidosis and glomerulonephritis [J].

Verschueren, P ;

Lensen, F ;

Lerut, E ;

Claes, K ;

De Vos, R ;

Van Damme, B ;

Westhovens, R .

ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (04) :368-369

← 1 2 →